Lfa Lugano Financial Advisors Sa Gilead Sciences, Inc. Transaction History

Lfa Lugano Financial Advisors Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $11,401 - $13,005	150 New	150 $11,000
Q3 2020 Oct 23, 2020	SELL	$62.1 - $78.08 $171,396 - $215,500	-2,760 Closed	0 $0
Q3 2018 Oct 11, 2018	BUY	$71.28 - $78.92 $110,056 - $121,852	1,544 Added 126.97%	2,760 $213,000
Q2 2018 Sep 04, 2018	SELL	$64.88 - $75.68 $5.47 Million - $6.38 Million	-84,318 Reduced 98.58%	1,216 $86,000
Q2 2018 Aug 30, 2018	BUY	$64.88 - $75.68 $5.55 Million - $6.47 Million	85,534 New	85,534 $86,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lfa Lugano Financial Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Lfa Lugano Financial Advisors Sa with notifications on news.